Latest News

Final Workshop Online: Advancing Breast Cancer Care Through Real-World Data

On September 16th, 2025, the REBECCA project held its final online workshop, bringing together a diverse group of stakeholders — including patients, healthcare professionals, researchers, and policy experts — all united by a common goal: to harness Real-World Data (RWD) to improve breast cancer m...

REBECCA Final Workshop in Rennes: Exploring patient trust, data privacy, and digital innovation in cancer care

On June 5th, 2025, the REBECCA project held its Final Workshop in Rennes, coinciding with the EHMA Conference 2025 organised by the European Health Management Association. This milestone event gathered a diverse group of stakeholders — including patients, healthcare professionals, researchers, an...

You’re Invited to join the Final REBECCA Workshop at the EHMA Conference 2025!

📍 Thursday, 5 June 2025 | 15:15 – 16:30 | Rennes, France As the REBECCA Project (REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data), funded by the EU’s Horizon 2020 programme, reaches its final phase, we’re excited to invite you to a dynamic an...

INCLIVA and Hospital Clínico de Valencia hold a meeting to bring research closer to breast cancer patients and understand their concerns

This article was authored by INCLIVA Biomedical Research Institute The Breast Cancer Biology Research Group at the INCLIVA Biomedical Research Institute and the Breast Cancer Unit at the Hospital Clínico de Valencia have organised a third meeting with patient associations...

REBECCA monitoring of prostate cancer patients

At Stavanger University Hospital (SUH) in Norway, efforts are focused on monitoring the quality of life of cancer patients affected by cancer-related fatigue (CRF) after primary treatment. In traditional clinical trials, patients’ quality of life and CRF status are typically assessed using questi...

An intervention study based on real-world data to improve quality of life after breast cancer treatment

Many breast cancer patients suffer from cancer-related fatigue (CRF) during and after primary treatment. Up to one-third experience chronic CRF, which can persist for as long as 10 years post-treatment. Fatigue significantly impacts patients’ quality of life, often hindering daily functioning. Th...

Characterisation of quality of life and late side-effects in breast cancer patients 

The observational REBECCA-CRF study (also called the REBECCA-1 study), conducted at Stavanger University Hospital (SUH) in Norway, aims to expand knowledge about the quality of life of patients affected by cancer-related fatigue (CRF) during and after cancer treatment. CRF is one of the most comm...

Voices of recovery: A Breast Cancer survivor’s journey with the REBECCA project

As the REBECCA project continues to make strides in enhancing the care and quality of life for breast cancer patients through real-world data, we are excited to share insights from a recent interview with a breast cancer survivor who participated in one of our studies. But before diving into the...

The Potential of Real-World Data from Breast Cancer Patients to Compare the Quality of Follow-Up in Chemotherapy or Radiotherapy Treatment

Real-world data, collected through devices and mobile applications, constitutes a valuable source of information about patients' behaviours and routines. This information allows for evaluating the impact of treatments on their quality of life, making more informed decisions to mitigate side effec...

Analysis of Lifestyle Data of Breast Cancer Patients to Assess Bone Health

The exploratory study on bone health REBECCA-OST, carried out in Spain INCLIVA Biomedical Research Institute, focuses on understanding the effects of adjuvant endocrine therapy with aromatase inhibitors on the bone health of breast cancer patients to improve their treatments. Although this treatm...